Robot-Assisted surgery shows promise for head and neck cancer

NCT ID NCT02517125

Completed Disease control Sponsor: Gustave Roussy, Cancer Campus, Grand Paris Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a newer robotic surgery system (Da Vinci Xi) for removing head and neck tumors through the mouth. It included 100 adults with various types and stages of head and neck cancer. The main goal was to see if the procedure could be done successfully and safely. The approach aims to reduce the need for large incisions and speed up recovery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Transoral robotic-assisted surgery with Da Vinci Xi (device)
What this could lead to: If successful, this could offer a less invasive surgical option for head and neck cancers, potentially reducing recovery time and side effects compared to open surgery.
What could go wrong: This is a small, early feasibility study (100 participants) with no control group. The device may not work for all tumor types or locations, and surgical risks like bleeding or infection remain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

head and neck cancer Head and Neck Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEAD AND NECK CANCER

Contacts and locations

Locations

Gustave Roussy Cancer Campus Grand Paris

Villejuif, Val de Marne, 94805, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.